Important role for Toll-like receptor 9 in host defense against meningococcal sepsis.
Neisseria meningitidis is a leading cause of meningitis and sepsis. The pathogenesis of meningococcal disease is determined by both bacterial virulence factors and the host inflammatory response. Toll-like receptors (TLRs) are prominent activators of the inflammatory response, and TLR2, -4, and -9 have been reported to be involved in the host response to N. meningitidis. While TLR4 has been suggested to play an important role in early containment of infection, the roles of TLR2 and TLR9 in meningococcal disease are not well described. Using a model for meningococcal sepsis, we report that TLR9(-/-) mice displayed reduced survival and elevated levels of bacteremia compared to wild-type mice. In contrast, TLR2(-/-) mice controlled the infection in a manner comparable to that of wild-type mice. TLR9 deficiency was also associated with reduced bactericidal activity in vitro, which was accompanied by reduced production of nitric oxide by TLR9-deficient macrophages. Interestingly, TLR9(-/-) mice recruited more macrophages to the bloodstream than wild-type mice and produced elevated levels of cytokines at late time points during infection. At the cellular level, activation of signal transduction and induction of cytokine gene expression were independent of TLR2 or TLR9 in macrophages and conventional dendritic cells. In contrast, plasmacytoid dendritic cells relied entirely on TLR9 to induce these activities. Thus, our data demonstrate an important role for TLR9 in host defense against N. meningitidis.
Sjölinder
Hong
H
Department of Medical Biochemistry and Microbiology, Biomedical Center, Uppsala University, P.O. Box 582, Uppsala, Sweden. hong.sjolinder@imbim.uu.se
Mogensen
Trine H
TH
Kilian
Mogens
M
Jonsson
Ann-Beth
AB
Paludan
Søren R
SR
D000818:Animals; D016470:Bacteremia / Q000276:immunology* / Q000378:metabolism; D016207:Cytokines / Q000235:genetics / Q000378:metabolism; D003713:Dendritic Cells / Q000276:immunology / Q000378:metabolism; D005260:Female; D015870:Gene Expression / Q000276:immunology; D008264:Macrophages / Q000276:immunology / Q000378:metabolism; D008589:Meningococcal Infections / Q000276:immunology* / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D009345:Neisseria meningitidis / Q000276:immunology* / Q000378:metabolism; D009569:Nitric Oxide / Q000096:biosynthesis; D015398:Signal Transduction / Q000276:immunology*; D051195:Toll-Like Receptor 2 / Q000276:immunology; D051217:Toll-Like Receptor 9 / Q000276:immunology* / Q000378:metabolism
D016207:Cytokines; C493486:Tlr2 protein, mouse; C495370:Tlr9 protein, mouse; D051195:Toll-Like Receptor 2; D051217:Toll-Like Receptor 9; D009569:Nitric Oxide
Cell Microbiol. 2007 Mar;9(3):657-69
17026481
J Exp Med. 2008 Jun 9;205(6):1277-83
18474631
Infect Immun. 1979 May;24(2):545-51
110703
J Exp Med. 2007 May 14;204(5):987-94
17452523
Proc Natl Acad Sci U S A. 2003 May 13;100(10):6075-80
12730365
Science. 1979 Jul 20;205(4403):298-9
451601
Infect Immun. 2004 Jan;72(1):371-80
14688118
Infect Immun. 2005 Oct;73(10):6838-45
16177362
Nat Rev Immunol. 2004 Jul;4(7):499-511
15229469
Pediatr Infect Dis J. 2006 Jan;25(1):80-1
16395111
J Clin Invest. 2005 Mar;115(3):695-702
15765149
J Immunol. 2007 Sep 15;179(6):3937-46
17785831
Infect Immun. 2008 Jan;76(1):189-97
17938219
Lancet Infect Dis. 2003 Sep;3(9):565-77
12954563
Nature. 2000 Dec 7;408(6813):740-5
11130078
Scand J Immunol. 2006 Dec;64(6):646-54
17083621
J Immunol. 2002 Feb 15;168(4):1533-7
11823477
J Immunol. 2004 Dec 1;173(11):6890-8
15557184
J Immunol. 2008 Feb 15;180(4):2474-85
18250457
J Leukoc Biol. 2006 Aug;80(2):267-77
16731773
N Engl J Med. 2001 May 3;344(18):1378-88
11333996
Eur J Immunol. 2007 Oct;37(10):2847-55
17853411
PLoS One. 2007 Feb 21;2(2):e241
17311106
Infect Immun. 1998 Jan;66(1):213-7
9423860
Infect Immun. 2006 Dec;74(12):6982-91
17030578
Infect Immun. 2006 Jun;74(6):3538-46
16714586
Cell. 2006 Feb 24;124(4):783-801
16497588
Respir Res. 2004 Nov 11;5:21
15538945
Cell Microbiol. 2007 Mar;9(3):633-44
17004992
J Exp Med. 2005 Dec 19;202(12):1715-24
16365150
J Virol. 2007 Dec;81(24):13315-24
17913820
Infect Immun. 2007 Jan;75(1):146-51
17060467
J Immunol. 2005 Apr 1;174(7):4295-300
15778393
FEMS Immunol Med Microbiol. 1999 Sep;25(4):385-9
10497870
J Immunol. 2006 Sep 15;177(6):3515-9
16951309